首页> 外国专利> SUBSTITUTED TETRA- AND PENTAPEPTIDE INHIBITORS OF PROTEIN:FARNESYL TRANSFERASE

SUBSTITUTED TETRA- AND PENTAPEPTIDE INHIBITORS OF PROTEIN:FARNESYL TRANSFERASE

机译:蛋白质:法尼基转移酶的取代的四肽和五肽抑制剂

摘要

Accordingly, the present invention is a substituted tetra- or pentapeptide compound of Formula I, wherein n is independently 1 or 2; A is Cbz or BnNHCO; R is independently H or Me; Y is independently H or Me; Z is independently H or Me; R4 is, wherein R4 is H or Me; R5 is wherein R5' is H, OH, -O-C1-6alkyl, -C1-6alkyl, CO-aryl, -(CH2)m-aryl, -O-(CH2)m- C3-10cycloalkyl, -O(CH2)m-aryl, -O(CH2)m-heteroaryl, wherein the definition of aryl is an aromatic ring which is a phenyl, 5-fluorenyl, 1-naphthyl or 2-naphthyl group, -I, -CF3, -NO2, -NH2, -NHCH3, -N(CH3)2, -NHCO-alkyl, -(CH2)mCO2H, -(CH2)m-CO2-alkyl,-(CH2)mSO3H, -(CH2)mPO3H2, -(CH2)mPO3(alkyl)2, -(CH2)mSO2NH2, and -(CH2)mSO2NH-alkyl wherein alkyl is C1-6-alkyl, m is 0, 1, 2, or 3 and wherein the definition of heteroaryl is a heteroaromatic ring which is a 2- or 3-thienyl, 2- or 3-furanyl, 2- or 3-pyrrolyl, 2-, 3- or 4-pyridyl, 2-, 3-, 4-, 5-, 6- or 7-indolyl group, substituted or unsubstituted by 1 or 2 substituents from the group of substituents described above for aryl, -OPO3(R5")2, -CH2PO3(R5'')2, -CF2PO3(R5'')2, or -CFHPO3(R5'')2, wherein R5' is located at either the ortho, meta, or para position and R5'' is H, C1-6alkyl-aryl wherein the definition of aryl is an aromatic ring which is as defined above or cyclohexyl, and m is independently 0, 1, 2 or 3, -COOR7, wherein R7 is H, Me, t-butyl, or benzyl; -SR8, wherein R8 is H or trityl; R6 is -OR6' wherein R6' is H, benzyl, -PO3R5''2, wherein R5'' is as described above; -CH2-R9, wherein R9 is -PO3R5''2, wherein R5'' is as described above; -SR6'', wherein R6'' is H, benzyl, or trityl, C is Gly, Ala, Val, Leu, Ile, Phe, Tyr, Tyr(OMe), Pgl, homoPhe, Trp, Trp(Me), or Trp(CHO); D is Gly, Ala, or absent; E is -OH, -NH2, -NHNH2, -NHR10, or -OR10 wherein R10 is H, C1-6alkyl, -(CH2)m-C3-10cycloalkyl, -(CH2)m-aryl, or -(CH2)m-heteroaryl, wherein aryl and heteroaryl and m is as described above; an isomer or a pharmaceutically acceptable salt thereof.
机译:因此,本发明是式I的取代的四肽或五肽化合物,其中n独立地为1或2; A为Cbz或BnNHCO; R独立地为H或Me; Y独立地为H或Me; Z独立地为H或Me; R4为,其中R4为H或Me; R5是其中R5'是H,OH,-O-C1-6烷基,-C1-6烷基,CO-芳基,-(CH2)m-芳基,-O-(CH2)m-C3-10环烷基,-O(CH2 )-芳基,-O(CH 2)m-杂芳基,其中芳基的定义是芳族环,该芳族环是苯基,-I,-CF 3,-NO 2,苯基,5-芴基,1-萘基或2-萘基, -NH2,-NHCH3,-N(CH3)2,-NHCO-烷基,-(CH2)mCO2H,-(CH2)m-CO2-烷基,-(CH2)mSO3H,-(CH2)mPO3H2,-(CH2) mPO 3(烷基)2,-(CH 2)mSO 2 NH 2和-(CH 2)mSO 2 NH-烷基,其中烷基是C 1-6-烷基,m是0、1、2或3,并且杂芳基的定义是杂芳环,其中是2-或3-噻吩基,2-或3-呋喃基,2-或3-吡咯基,2-,3-或4-吡啶基,2-,3-,4-,5-,6-或7-吲哚基,被上述芳基,-OPO3(R5“)2,-CH2PO3(R5'')2,-CF2PO3(R5'')2或-CFHPO3取代基中的1个或2个取代基取代或未取代(R5″)2,其中R5′位于邻,间或对位,并且R5″是H,C1-6烷基-芳基,其中芳基的定义是如定义的芳环。式中,R 7为H,Me,叔丁基或苄基;并且m独立地为0、1、2或3,-COOR 7,其中R 7为H,Me,叔丁基或苄基; -SR8,其中R8是H或三苯甲基; R6为-OR6',其中R6'为H,苄基,-PO3R5''2,其中R5''如上所述。 -CH 2 -R 9,其中R 9为-PO 3 R 5″ 2,其中R 5″如上所述。 -SR6'',其中R6''是H,苄基或三苯甲基,C是Gly,Ala,Val,Leu,Ile,Phe,Tyr,Tyr(OMe),Pgl,homoPhe,Trp,Trp(Me)或色氨酸(CHO); D是Gly,Ala或不存在; E为-OH,-NH 2,-NHNH 2,-NHR 10或-OR 10,其中R 10为H,C 1-6烷基,-(CH 2)m -C 3-10环烷基,-(CH 2)m-芳基或-(CH 2)m -杂芳基,其中芳基和杂芳基和m如上所述。异构体或其药学上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号